Research
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g445 (Published 30 January 2014) Cite this as: BMJ 2014;348:g445
Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Appendix: Risk of hospital admission and mortality with additional adjustment for time in hospital before start of study
Related articles
- Paper Published: 04 September 2003; BMJ 327 doi:10.1136/bmj.327.7414.523
- Clinical Review Published: 02 January 2015; BMJ 349 doi:10.1136/bmj.g7617
See more
- What it feels like to be an interesting teaching opportunityBMJ December 07, 2016, 355 i6190; DOI: https://doi.org/10.1136/bmj.i6190
- Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysisBMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188
- Doctors face manslaughter charge for failing to raise alarm over killer nurseBMJ December 01, 2016, 355 i6507; DOI: https://doi.org/10.1136/bmj.i6507
- Trial of novel leukaemia drug is stopped for second time after two more deathsBMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376
- Thiazide diuretics seem to protect against fractureBMJ November 22, 2016, 355 i6263; DOI: https://doi.org/10.1136/bmj.i6263
Cited by...
- Call to action for primary care symptom management in end-stage lung disease
- Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis
- Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol
- Morphine for dyspnoea in chronic obstructive pulmonary disease: a before-after efficacy study
- Pharmacological and nonpharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis
- Morbidity and mortality associated with prescription cannabinoid drug use in COPD
- Validation of the Swedevox registry of continuous positive airway pressure, long-term mechanical ventilator and long-term oxygen therapy
- Course of DISease In patients reported to the Swedish CPAP Oxygen and VEntilator RegistrY (DISCOVERY) with population-based controls
- Opioids for breathlessness: a narrative review
- Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease
- Attitudes of patients with chronic breathlessness towards treatment with opioids
- Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial
- Palliative treatment of chronic breathlessness syndrome: the need for P5 medicine
- Improving the quality of life of people with advanced respiratory disease and severe breathlessness
- Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness
- Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study
- Chronic breathlessness: time for Cinderella to go to the ball!
- Adverse respiratory effects of opioids for chronic breathlessness: to what extent can we learn lessons from chronic pain?
- Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions
- Updates in palliative care - recent advancements in the pharmacological management of symptoms
- Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis
- A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol
- Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness
- Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness
- Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients
- Opioids in COPD: a cause of death or a marker of illness severity?
- Using routine data to improve palliative and end of life care
- Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing
- Incident opioid drug use and adverse respiratory outcomes among older adults with COPD
- Managing breathlessness: a palliative care approach
- End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study
- End-of-life care in oxygen-dependent COPD and cancer: a national population-based study
- Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
- Response to Ekstrom et al regarding low-dose opioids in advanced chronic obstructive pulmonary disease
- Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD
- Pain in patients with COPD: a systematic review and meta-analysis
- Benzodiazepines and opioids need to be prescribed with caution in advanced COPD
- Should we exercise caution with benzodiazepine use in patients with COPD?
- Palliative care of chronic progressive lung disease
- Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
- The management of chronic breathlessness in patients with advanced and terminal illness